MLL Legal advised the shareholders in the sale of Suter Group, a major supplier of mobile pellet heating and dehumidification solutions, mainly for construction sites, to Nord Holding, a prominent European private equity manager.
Tags :Philipp Falk
MLL Legal acted as transaction counsel for the owners of Novasina and SIC Group on the sale of Novasina. Novasina specializes in the development and manufacturing of precision measuring instruments for water activity, air and
MLL has announced that Daniel Donauer, Philipp Falk, Alexandre Fokiadès, Yannik Hässig, Matthias Leemann, Michael Schüepp, Andrea Viest and Stefan Wandel have been promoted to Senior Associates. Daniel Donauer practises in
MLL Legal has advised the owners of cargopack group regarding the sale of the company and its subsidiaries to the Swedish company Nefab. The acquisition of cargopack group, a renowed Swiss company focus in industrial
MLL acted as lead counsel to Crest Rock Partners, a Denver-based private equity fund, on a transaction that led to a strategic growth investment in Pitcher. The Zurich based company is a provider of sales
Shareholders of the UK-based Axis Electronics (Axis) has completed the sale of their shares to SIX listed Cicor Group. Founded originally as part of an international electronics company, Axis was established in 1995 as an independent,
MLL advised Calida Group, a global clothing group, with regard to the strategic acquisition of erlich textile. The German based company stands for underwear products manufactured in Europe from top-quality textiles made from organic and
SIC Group, a Swiss industrial investor backed by Swiss KMU Partners, has invested in Sauter, Bachmann, a company engaged in developing and producing high-precision gears and gearboxes for Swiss and international clients in the aerospace
Nexira, experts in natural plant-based ingredients for the food, nutrition and health industries, acquired Unipekin Ingredients, specialists in natural ingredients for the food industry. Swiss-based Unipektin Ingredients produces natural ingredients for the food industry. The
AFFiRiS biotechnology company has entered into a definitive agreement with AC Immune in regards to the sale of its entire portfolio of anti-alpha-synclein immunotherapies in exchange for shares in AC Immune with regard to all